July 9 (Reuters) - Verona Pharma PLC I9SAy.F:
MERCK TO ACQUIRE VERONA PHARMA, EXPANDING ITS PORTFOLIO TO INCLUDE OHTUVAYRE® (ENSIFENTRINE), A FIRST-IN-CLASS COPD MAINTENANCE TREATMENT FOR ADULTS AND EXPECTED TO DRIVE GROWTH INTO THE NEXT DECADE
VERONA PHARMA PLC - MERCK TO BUY VERONA PHARMA FOR $10 BILLION
VERONA PHARMA PLC - MERCK TO PAY $107 PER ADS IN VERONA PHARMA DEAL
VERONA PHARMA PLC - DEAL EXPECTED TO CLOSE IN Q4 2025
VERONA PHARMA PLC - MERCK AND VERONA PHARMA BOARDS APPROVE DEAL
Further company coverage: [I9SAy.F]